$LYTS
LSI INDUSTRIES INC

2017 Q3 Form 10-Q Financial Statement

#000143774917018417 Filed on November 06, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3 2015 Q4
Revenue $87.47M $84.16M $84.69M
YoY Change 3.93% -2.06% -0.03%
Cost Of Revenue $63.76M $62.82M $60.76M
YoY Change 1.5% 0.39% -5.3%
Gross Profit $23.70M $20.84M $23.93M
YoY Change 13.77% -10.77% 16.4%
Gross Profit Margin 27.1% 24.76% 28.25%
Selling, General & Admin $20.52M $19.62M $18.55M
YoY Change 4.59% 11.54% 1.17%
% of Gross Profit 86.56% 94.15% 77.51%
Research & Development $1.562M $1.401M $1.320M
YoY Change 11.49% 6.86% -8.97%
% of Gross Profit 6.59% 6.72% 5.52%
Depreciation & Amortization $2.572M $1.835M $1.598M
YoY Change 40.16% 16.43% 2.96%
% of Gross Profit 10.85% 8.81% 6.68%
Operating Expenses $22.08M $21.02M $19.87M
YoY Change 5.05% 11.22% 0.43%
Operating Profit -$24.81M $1.066M $5.380M
YoY Change -2427.77% -81.5% 141.91%
Interest Expense $411.0K $13.00K $9.000K
YoY Change 3061.54% 62.5% -25.0%
% of Operating Profit 1.22% 0.17%
Other Income/Expense, Net
YoY Change
Pretax Income -$25.22M $1.080M $5.388M
YoY Change -2434.91% -81.26% 142.92%
Income Tax -$9.588M $251.0K $1.606M
% Of Pretax Income 23.24% 29.81%
Net Earnings -$15.63M $829.0K $3.782M
YoY Change -1985.28% -77.89% 138.16%
Net Earnings / Revenue -17.87% 0.99% 4.47%
Basic Earnings Per Share -$0.61 $0.03 $0.15
Diluted Earnings Per Share -$0.61 $0.03 $0.15
COMMON SHARES
Basic Shares Outstanding 25.79M 25.28M 24.91M
Diluted Shares Outstanding 25.79M 25.91M 25.62M

Balance Sheet

Concept 2017 Q3 2016 Q3 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.100M $30.70M $28.80M
YoY Change -93.16% 8.1% 59.12%
Cash & Equivalents $2.120M $30.71M $33.84M
Short-Term Investments
Other Short-Term Assets $3.400M $3.500M $7.400M
YoY Change -2.86% -50.0% 12.12%
Inventory $49.18M $43.60M $45.89M
Prepaid Expenses
Receivables $54.30M $46.20M $43.10M
Other Receivables $0.00 $0.00 $600.0K
Total Short-Term Assets $109.0M $124.0M $125.8M
YoY Change -12.12% -2.05% 13.43%
LONG-TERM ASSETS
Property, Plant & Equipment $45.98M $47.69M $43.72M
YoY Change -3.58% 9.38% -1.32%
Goodwill $30.54M $10.51M $10.51M
YoY Change 190.62%
Intangibles $37.48M $5.479M $5.839M
YoY Change 584.05%
Long-Term Investments
YoY Change
Other Assets $16.22M $5.144M $1.679M
YoY Change 215.24% 185.78% 4.94%
Total Long-Term Assets $130.2M $68.82M $61.74M
YoY Change 89.21% 11.36% -1.84%
TOTAL ASSETS
Total Short-Term Assets $109.0M $124.0M $125.8M
Total Long-Term Assets $130.2M $68.82M $61.74M
Total Assets $239.2M $192.8M $187.5M
YoY Change 24.04% 2.35% 7.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.84M $14.28M $8.829M
YoY Change 24.91% -7.25% -31.02%
Accrued Expenses $23.50M $20.51M $23.31M
YoY Change 14.62% 15.85% 39.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $41.35M $34.79M $32.14M
YoY Change 18.84% -6.48% 4.34%
LONG-TERM LIABILITIES
Long-Term Debt $51.86M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.587M $1.144M $2.099M
YoY Change 38.72% -48.0% -0.05%
Total Long-Term Liabilities $53.45M $1.144M $2.099M
YoY Change 4572.12% -48.0% -0.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $41.35M $34.79M $32.14M
Total Long-Term Liabilities $53.45M $1.144M $2.099M
Total Liabilities $94.80M $35.93M $34.24M
YoY Change 163.8% -8.56% 4.06%
SHAREHOLDERS EQUITY
Retained Earnings $22.90M $41.44M $42.41M
YoY Change -44.73%
Common Stock $121.5M $115.5M $110.9M
YoY Change 5.23%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.180M $2.469M $2.375M
YoY Change -11.69%
Treasury Stock Shares $241.1K $258.7K $250.1K
Shareholders Equity $144.4M $156.9M $153.3M
YoY Change
Total Liabilities & Shareholders Equity $239.2M $192.8M $187.5M
YoY Change 24.04% 2.35% 7.9%

Cashflow Statement

Concept 2017 Q3 2016 Q3 2015 Q4
OPERATING ACTIVITIES
Net Income -$15.63M $829.0K $3.782M
YoY Change -1985.28% -77.89% 138.16%
Depreciation, Depletion And Amortization $2.572M $1.835M $1.598M
YoY Change 40.16% 16.43% 2.96%
Cash From Operating Activities -$2.725M $339.0K $2.540M
YoY Change -903.83% -88.52% -76.7%
INVESTING ACTIVITIES
Capital Expenditures $498.0K $1.960M $2.022M
YoY Change -74.59% 43.91% 41.0%
Acquisitions
YoY Change
Other Investing Activities $1.530M $0.00
YoY Change -100.0%
Cash From Investing Activities $1.029M -$1.960M -$2.020M
YoY Change -152.5% 43.91% 41.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $106.0K $344.0K
YoY Change -69.19% 50.88%
Debt Paid & Issued, Net $22.25M
YoY Change
Cash From Financing Activities 777.0K -1.500M -150.0K
YoY Change -151.8% -488.6% -6.25%
NET CHANGE
Cash From Operating Activities -2.725M 339.0K 2.540M
Cash From Investing Activities 1.029M -1.960M -2.020M
Cash From Financing Activities 777.0K -1.500M -150.0K
Net Change In Cash -919.0K -3.121M 370.0K
YoY Change -70.55% -257.95% -96.03%
FREE CASH FLOW
Cash From Operating Activities -$2.725M $339.0K $2.540M
Capital Expenditures $498.0K $1.960M $2.022M
Free Cash Flow -$3.223M -$1.621M $518.0K
YoY Change 98.83% -201.95% -94.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 lyts Adjustments To Severance Liability
AdjustmentsToSeveranceLiability
-14000
CY2017Q3 lyts Accrued Severance Liability
AccruedSeveranceLiability
CY2016Q3 lyts Accrued Severance Liability
AccruedSeveranceLiability
145000
CY2017 lyts Accrued Severance Liability
AccruedSeveranceLiability
523000
CY2017Q3 lyts Adjustments To Severance Liability
AdjustmentsToSeveranceLiability
CY2016Q3 lyts Adjustments To Severance Liability
AdjustmentsToSeveranceLiability
CY2017Q3 lyts Deferred Compensation Plan Number Of Participants
DeferredCompensationPlanNumberOfParticipants
38
CY2017Q3 lyts Dividends Accrued
DividendsAccrued
29106
CY2016Q3 lyts Dividends Accrued
DividendsAccrued
13898
lyts Issuance Of Common Stock As Compensation
IssuanceOfCommonStockAsCompensation
78000
CY2016Q3 lyts Increase Decrease In Common Stock Related To Stock Option Exercise
IncreaseDecreaseInCommonStockRelatedToStockOptionExercise
165856
CY2017Q3 lyts Increase Decrease In Expense Related To Stock Option Exercise
IncreaseDecreaseInExpenseRelatedToStockOptionExercise
81010
CY2017Q3 lyts Reduction Of Deferred Tax Asset Related To Stock Option Exercises
ReductionOfDeferredTaxAssetRelatedToStockOptionExercises
180006
CY2016Q3 lyts Reduction Of Deferred Tax Asset Related To Stock Option Exercises
ReductionOfDeferredTaxAssetRelatedToStockOptionExercises
183665
lyts Issuance Of Common Stock As Compensation
IssuanceOfCommonStockAsCompensation
103000
CY2017Q3 lyts Number Of Revenue Sources
NumberOfRevenueSources
5
CY2017Q3 lyts Payments For Severance Liability
PaymentsForSeveranceLiability
159000
CY2016Q3 lyts Payments For Severance Liability
PaymentsForSeveranceLiability
119000
CY2017 lyts Payments For Severance Liability
PaymentsForSeveranceLiability
313000
lyts Proceeds And Tax Benefit From Stock Options Exercised
ProceedsAndTaxBenefitFromStockOptionsExercised
115000
lyts Proceeds And Tax Benefit From Stock Options Exercised
ProceedsAndTaxBenefitFromStockOptionsExercised
58000
CY2017Q3 lyts Reduction Of Federal Income Taxes Payable Related To Stock Option Exercise
ReductionOfFederalIncomeTaxesPayableRelatedToStockOptionExercise
104969
CY2016Q3 lyts Reduction Of Federal Income Taxes Payable Related To Stock Option Exercise
ReductionOfFederalIncomeTaxesPayableRelatedToStockOptionExercise
78040
CY2017Q3 lyts Reduction Of Income Tax Expense Related To Stock Option Exercises
ReductionOfIncomeTaxExpenseRelatedToStockOptionExercises
5973
CY2016Q3 lyts Reduction Of Income Tax Expense Related To Stock Option Exercises
ReductionOfIncomeTaxExpenseRelatedToStockOptionExercises
8880
CY2017Q3 lyts Restructuring And Related Cost Incurred Cost Gain
RestructuringAndRelatedCostIncurredCostGain
CY2016Q3 lyts Restructuring And Related Cost Incurred Cost Gain
RestructuringAndRelatedCostIncurredCostGain
656000
CY2017Q3 lyts Restructuring Costs Cost Of Goods Sold
RestructuringCostsCostOfGoodsSold
CY2016Q3 lyts Restructuring Costs Cost Of Goods Sold
RestructuringCostsCostOfGoodsSold
503000
CY2017Q3 lyts Restructuring Costs Operating Expenses
RestructuringCostsOperatingExpenses
CY2016Q3 lyts Restructuring Costs Operating Expenses
RestructuringCostsOperatingExpenses
153000
CY2017Q3 lyts Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodAggregateGrantDateFairValue
1377325
CY2016Q3 lyts Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Aggregate Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodAggregateGrantDateFairValue
1334248
CY2017Q3 lyts Share Based Compensation Valuation Assumptions Expected Forfeiture Rate
ShareBasedCompensationValuationAssumptionsExpectedForfeitureRate
0.083
CY2017Q3 lyts Treasury Stock Acquired Repurchase Authorization Shares Expected
TreasuryStockAcquiredRepurchaseAuthorizationSharesExpected
15225
CY2017Q3 lyts Weighted Average Number Of Shares Issued Net Of Treasury Shares Basic
WeightedAverageNumberOfSharesIssuedNetOfTreasurySharesBasic
25505000
CY2016Q3 lyts Weighted Average Number Of Shares Issued Net Of Treasury Shares Basic
WeightedAverageNumberOfSharesIssuedNetOfTreasurySharesBasic
24998000
CY2017Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
54252000
CY2017Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
48880000
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
17842000
CY2017Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
19356000
CY2017Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
54688000
CY2017Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
49386000
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
23504000
CY2017Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26069000
CY2017Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1986000
CY2017Q2 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
2314000
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78615000
CY2017Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
77147000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
436000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
506000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
436000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
293000
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
690000
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
107000
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3791936
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1654450
CY2017Q3 us-gaap Assets
Assets
239189000
CY2017Q2 us-gaap Assets
Assets
256680000
CY2017Q3 us-gaap Assets Current
AssetsCurrent
108974000
CY2017Q2 us-gaap Assets Current
AssetsCurrent
107129000
CY2017Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
CY2017Q2 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
1463000
CY2017Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
35686000
CY2017Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
35463000
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2120000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3039000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3039000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33835000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30714000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-919000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3121000
CY2017Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
5080127
CY2017Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
4615000
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2017Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25535362
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24997531
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
121490000
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
120259000
CY2017Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
652000
CY2017Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
3805000
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
63763000
CY2016Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62821000
CY2017Q3 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
31922
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10815000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-825000
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1480000
CY2017Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1061000
CY2017Q3 us-gaap Depreciation
Depreciation
1882000
CY2016Q3 us-gaap Depreciation
Depreciation
1728000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2572000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1835000
CY2017Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2572000
CY2016Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1835000
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.38
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.232
CY2017Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.337
CY2016Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.32
CY2017Q3 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
CY2016Q3 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.067
CY2017Q3 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.048
CY2016Q3 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
CY2017Q3 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
CY2016Q3 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.008
CY2017Q3 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.002
CY2016Q3 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.013
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6867000
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9759000
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3029686
CY2017Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y30D
CY2017Q3 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Asset
FairValueDisclosureOffbalanceSheetRisksAmountAsset
0
CY2017Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21278000
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
20588000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
21397000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2760000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2461000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2682000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2687000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2760000
CY2017Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
55335000
CY2017Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
55335000
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34057000
CY2017Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
34747000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
31000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-1000
CY2017Q3 us-gaap Goodwill
Goodwill
30538000
CY2017Q2 us-gaap Goodwill
Goodwill
58538000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
28000000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2017Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
28000000
CY2016Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
CY2017Q3 us-gaap Gross Profit
GrossProfit
23703000
CY2016Q3 us-gaap Gross Profit
GrossProfit
20835000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
273000
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-25217000
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1080000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9588000
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
251000
CY2017Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2016Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
1022000
CY2017Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
CY2017Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
775000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
5421000
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-628000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1559000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
121000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3243000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5487000
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
419000
us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
268000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-413000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
198000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-775000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-683000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
286000
CY2016Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
914000
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2016Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
637000
CY2017Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3422000
CY2017Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
3422000
CY2017Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37479000
CY2017Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
38169000
CY2017Q3 us-gaap Interest Expense
InterestExpense
411000
CY2016Q3 us-gaap Interest Expense
InterestExpense
13000
CY2017Q3 us-gaap Interest Paid Net
InterestPaidNet
382000
CY2016Q3 us-gaap Interest Paid Net
InterestPaidNet
13000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1460000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1500000
CY2017Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3527000
us-gaap Inventory Write Down
InventoryWriteDown
143000
us-gaap Inventory Write Down
InventoryWriteDown
573000
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
27000
CY2017Q3 us-gaap Land
Land
6469000
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14401000
CY2017Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
14060000
CY2017Q3 us-gaap Inventory Net
InventoryNet
49182000
CY2017Q2 us-gaap Inventory Net
InventoryNet
50008000
CY2017Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
31332000
CY2017Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
32421000
CY2017Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3449000
CY2017Q2 us-gaap Land
Land
6429000
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
239189000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
256680000
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
41346000
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
45425000
CY2017Q3 us-gaap Line Of Credit
LineOfCredit
51900000
CY2017Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
48100000
CY2017Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
51862000
CY2017Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
49698000
CY2017Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
81790000
CY2017Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
78804000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1029000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1960000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3408000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
339000
us-gaap Net Income Loss
NetIncomeLoss
-15629000
us-gaap Net Income Loss
NetIncomeLoss
829000
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-15629000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
829000
CY2017Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2017Q3 us-gaap Number Of Reporting Units
NumberOfReportingUnits
3
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-24814000
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1066000
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6502000
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5375000
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
16216000
CY2017Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5490000
CY2017Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
58757000
CY2017Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
58757000
CY2017Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1587000
CY2017Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1479000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
106000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
344000
CY2017Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
43000
CY2017Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1286000
CY2016Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1256000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1286000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1256000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
498000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1960000
CY2017Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
498000
CY2016Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1960000
CY2017Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2017Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3420000
CY2017Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2964000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
24411000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1527000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
573000
us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
42000
CY2017Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
114770
CY2016Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
173185
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
124597000
CY2017Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
124501000
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45982000
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
47354000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
49000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
113000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
22247000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1562000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1401000
CY2016Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
656000
CY2017Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
CY2017Q3 us-gaap Restructuring Charges
RestructuringCharges
CY2017Q2 us-gaap Restructuring Reserve
RestructuringReserve
85000
CY2017Q3 us-gaap Restructuring Reserve
RestructuringReserve
42000
CY2017Q3 us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
22904000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
39819000
CY2017Q3 us-gaap Sales Revenue Net
SalesRevenueNet
87466000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
84159000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8338974
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8783980
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3593365
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3119688
CY2017Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20517000
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19616000
CY2017Q3 us-gaap Severance Costs1
SeveranceCosts1
0
CY2016Q3 us-gaap Severance Costs1
SeveranceCosts1
145000
us-gaap Share Based Compensation
ShareBasedCompensation
984000
us-gaap Share Based Compensation
ShareBasedCompensation
1741000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1366738
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1536124
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1586188
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.26
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.91
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
20156
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
50160
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
232171
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
140250
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
724037
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
832500
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.71
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.83
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2332224
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
646326
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2976490
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3647927
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.12
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.18
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.97
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.18
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
594220
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3479522
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
8.21
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
8550
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
9470
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.31
CY2016Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.32
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.92
CY2016Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.95
CY2017Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.92
CY2016Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.06
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
111768
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4.982876
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P9Y300D
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y36D
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1842127
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
2057241
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
124321
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
3.49
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.52
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
2.87
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y146D
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y219D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y219D
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y109D
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y219D
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
384602
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
3.58
CY2017Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
6669000
CY2017Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7560000
CY2016Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5069000
CY2016Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5348000
CY2017Q3 us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
CY2016Q3 us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
CY2017 us-gaap Standard Product Warranty Accrual Additions From Business Acquisition
StandardProductWarrantyAccrualAdditionsFromBusinessAcquisition
907000
CY2017Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
1818000
CY2016Q3 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
624000
CY2017 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
3372000
CY2017Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
927000
CY2016Q3 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
903000
CY2017 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
4956000
CY2017Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18189
CY2016Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20813
CY2017Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
77976
CY2016Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
103100
CY2017Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
757808
CY2016Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1438443
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
144394000
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
160078000
CY2017Q2 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
235000
CY2016Q2 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
39000
CY2017Q3 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
76000
CY2016Q3 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
65000
CY2017Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
241095
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
257898
CY2017Q3 us-gaap Treasury Stock Value
TreasuryStockValue
2180397
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
2456875
CY2017Q3 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Use of Estimates:</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The preparation of the financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes.<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;&nbsp;Actual results could differ from those estimates.</div></div></div></div></div></div></div>
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25791000
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25912000
CY2017Q3 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
245000
CY2016Q3 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
240000
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25791000
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25275000

Files In Submission

Name View Source Status
0001437749-17-018417-index-headers.html Edgar Link pending
0001437749-17-018417-index.html Edgar Link pending
0001437749-17-018417.txt Edgar Link pending
0001437749-17-018417-xbrl.zip Edgar Link pending
ex_98714.htm Edgar Link pending
ex_98715.htm Edgar Link pending
ex_98716.htm Edgar Link pending
ex_98717.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lyts-20170930.xml Edgar Link completed
lyts-20170930.xsd Edgar Link pending
lyts-20170930_cal.xml Edgar Link unprocessable
lyts-20170930_def.xml Edgar Link unprocessable
lyts-20170930_lab.xml Edgar Link unprocessable
lyts-20170930_pre.xml Edgar Link unprocessable
lyts20170930_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending